Showing results (671-680 of 1,000) with videos related to
Sort By:
Pageof 100
Assay and Drug Development Technologies|August 9, 2014
A cell-based functional assay using a green fluorescent protein-based calcium indicator dCys-GCaMPBin Cai, Xia Chen, Fang Liu, et al.Assay and Drug Development Technologies|April 15, 2016
Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule ScreeningKarin Engen, Ulrika Rosenström, Hanna Axelsson, et al.Assay and Drug Development Technologies|July 26, 2017
High-Throughput Analysis Identifying Drugs That Regulate Apolipoprotein A-I SynthesisMichael J Haas, Luisa Onstead-Haas, William Kurban, et al.Assay and Drug Development Technologies|August 12, 2017
How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of PracticeDorothea Haasen, Ulrich Schopfer, Christophe Antczak, et al.Assay and Drug Development Technologies|December 31, 2015
Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks BarracudaRok Cerne, Mark Wakulchik, Baolin Li, et al.Assay and Drug Development Technologies|May 18, 2016
Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS DataHans De Wolf, An De Bondt, Heather Turner, et al.Assay and Drug Development Technologies|August 23, 2014
A comparison of assay performance between the calcium mobilization and the dynamic mass redistribution technologies for the human urotensin receptorMi Young Lee, Jihye Mun, Jeong Hyun Lee, et al.Assay and Drug Development Technologies|November 22, 2014
Assessing HTS performance using BioAssay Ontology: screening and analysis of a bacterial phospho-N-acetylmuramoyl-pentapeptide translocase campaignAndreas Moberg, Linda Zander Balderud, Eva Hansson, et al.Assay and Drug Development Technologies|November 11, 2014
Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C)Mark R Swingle, Richard E HonkanenAssay and Drug Development Technologies|June 25, 2016
Benefits of Strategic Small-Scale Targeted ScreeningElizabeth R SharlowPageof 100